Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Asper Biotech's LHON and Alström Syndrome Tests

Premium

Asper Biotech recently launched a test for Leber hereditary optic neuropathy, or LHON, a disease characterized by optic nerve dysfunction that leads to painless, subacute loss of central vision. It is caused by mutations in mitochondrial DNA and is transmitted by maternal inheritance.

Asper's LHON genetic test can detect all three primary mutations associated with LHON. The test is available as a service that includes DNA extraction, genotyping by array-based primer extension, and data interpretation.

Asper also recently added 13 markers to its array for Alström syndrome. The test surveys the ALMS1 gene for mutations. Alström syndrome is characterized by cone-rod dystrophy, obesity, progressive sensorineural hearing impairment, dilated cardiomyopathy, insulin resistance syndrome, developmental delay, and progressive hepatic and renal dysfunction. The syndrome is rare. According to Alström Syndrome International, about 800 cases of Alström syndrome have been identified worldwide.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.